Ignite Creation Date:
2024-05-06 @ 1:38 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01857193
Status:
COMPLETED
Last Update Posted:
2021-04-13
First Post:
2013-05-16
Brief Title:
Phase Ib Trial of LEE011 With Everolimus RAD001 and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-06
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-16
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-16
First Submit QC Date:
May 16 2013
Study First Post Date:
2013-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-08
Last Update Post Date:
2021-04-13
Last Update Post Date Type:
ACTUAL